文献速递药物不良反应与药物警戒特殊人群用药

机器学习识别卡铂、紫杉烷和贝伐珠单抗治疗卵巢癌患者高血压的胚系标志物

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
PubMed 文献 · Clin Pharmacol Ther · 2023-06-21

该研究利用机器学习分析171例接受卡铂、紫杉烷和贝伐珠单抗治疗的卵巢癌患者的超过60个候选基因的SNV,识别与药物毒性相关的遗传变异。研究构建的多基因毒性风险评分可将患者分为高血压高风险和低风险,高风险患者发生高血压的可能性是低风险患者的28倍。

要点

  • 机器学习可从多基因SNV中识别化疗相关毒性标志物。
  • 多基因风险评分将患者分为高血压高风险和低风险。
  • 高风险患者发生高血压的风险是低风险患者的28倍。

核心结论

  • 机器学习方法可识别与卡铂、紫杉烷和贝伐珠单抗诱导毒性相关的SNV,并构建多基因风险评分预测高血压风险。

研究设计与样本

  • 研究纳入MITO-16A/MaNGO-OV2A试验中171例卵巢癌患者,分析超过60个候选基因的SNV,使用Boruta算法和交叉验证筛选重要SNV,并训练eXtreme gradient boosting模型。

主要发现

  • 交叉验证中模型Matthews相关系数为0.375至0.410。
  • 共识别43个对预测毒性关键的SNV。
  • 针对每种毒性,关键SNV构建的多基因毒性风险评分可将个体分为高风险和低风险。
  • 与低风险个体相比,高风险患者发生高血压的可能性高28倍。

临床怎么用

  • 该多基因风险评分可用于识别接受卡铂、紫杉烷和贝伐珠单抗治疗的卵巢癌患者中高血压高风险个体,辅助毒性监测和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacogenomics studies how genes influence a person's response to treatment. When complex phenotypes are influenced by multiple genetic variations with little effect, a single piece of genetic information is often insufficient to explain this variability. The application of machine learning (ML) in pharmacogenomics holds great potential - namely, it can be used to unravel complicated genetic relationships that could explain response to therapy. In this study, ML techniques were used to investigate the relationship between genetic variations affecting more than 60 candidate genes and carboplatin-induced, taxane-induced, and bevacizumab-induced toxicities in 171 patients with ovarian cancer enrolled in the MITO-16A/MaNGO-OV2A trial. Single-nucleotide variation (SNV, formerly SNP) profiles were examined using ML to find and prioritize those associated with drug-induced toxicities, specifically hypertension, hematological toxicity, nonhematological toxicity, and proteinuria. The Boruta algorithm was used in cross-validation to determine the significance of SNVs in predicting toxicities. Important SNVs were then used to train eXtreme gradient boosting models. During cross-validation, the models achieved reliable performance with a Matthews correlation coefficient ranging from 0.375 to 0.410. A total of 43 SNVs critical for predicting toxicity were identified. For each toxicity, key SNVs were used to create a polygenic toxicity risk score that effectively divided individuals into high-risk and low-risk categories. In particular, compared with low-risk individuals, high-risk patients were 28-fold more likely to develop hypertension. The proposed method provided insightful data to improve precision medicine for patients with ovarian cancer, which may be useful for reducing toxicities and improving toxicity management.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Polano M, Bedon L, Dal Bo M, et al. Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab. Clin Pharmacol Ther. 2023. PMID: 37243926. doi:10.1002/cpt.2960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。